BRPI0810835A2 - Formulações de hidroquinona ansamicina - Google Patents

Formulações de hidroquinona ansamicina

Info

Publication number: BRPI0810835A2
Authority: BR; Brazil
Prior art keywords: anxamycin; hydroquinone; formulations; hydroquinone formulations; anxamycin hydroquinone
Prior art date: 2007-04-12

Application number

BRPI0810835-8A

Other languages

English (en)

Inventor

James L Wright

James R Porter

Original Assignee

Infinity Discovery Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-12

Filing date

2008-04-11

Publication date

2015-06-16

2008-04-11 Application filed by Infinity Discovery Inc filed Critical Infinity Discovery Inc

2015-06-16 Publication of BRPI0810835A2 publication Critical patent/BRPI0810835A2/pt

Links

QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 title 2
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

BRPI0810835-8A 2007-04-12 2008-04-11 Formulações de hidroquinona ansamicina BRPI0810835A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US91133007P	2007-04-12	2007-04-12
PCT/US2008/060063 WO2008128063A1 (en)	2007-04-12	2008-04-11	Hydroquinone ansamycin formulations

Publications (1)

Publication Number	Publication Date
BRPI0810835A2 true BRPI0810835A2 (pt)	2015-06-16

Family

ID=39628966

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0810835-8A BRPI0810835A2 (pt)	2007-04-12	2008-04-11	Formulações de hidroquinona ansamicina

Country Status (10)

Country	Link
US (1)	US20080255080A1 (pt)
EP (1)	EP2134338A1 (pt)
JP (1)	JP2010523710A (pt)
CN (1)	CN101677991A (pt)
AU (1)	AU2008240179A1 (pt)
BR (1)	BRPI0810835A2 (pt)
CA (1)	CA2684211A1 (pt)
IL (1)	IL201283A0 (pt)
MX (1)	MX2009010808A (pt)
WO (1)	WO2008128063A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7282493B2 (en)	2003-12-23	2007-10-16	Infinity Pharmaceuticals, Inc.	Analogs of benzoquinone-containing ansamycins and methods of use thereof
EP2348845A4 (en)	2008-10-15	2013-01-23	Infinity Pharmaceuticals Inc	ANSAMYCIN HYDROQUINONE COMPOSITIONS
CN115227692A (zh) *	2022-09-05	2022-10-25	中国医学科学院基础医学研究所	Reblastatin在制备治疗慢性惊厥的药物中的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4261989A (en) *	1979-02-19	1981-04-14	Kaken Chemical Co. Ltd.	Geldanamycin derivatives and antitumor drug
US4762857A (en) *	1986-05-30	1988-08-09	E. I. Du Pont De Nemours And Company	Trehalose as stabilizer and tableting excipient
US5387584A (en) *	1993-04-07	1995-02-07	Pfizer Inc.	Bicyclic ansamycins
US5932566A (en) *	1994-06-16	1999-08-03	Pfizer Inc.	Ansamycin derivatives as antioncogene and anticancer agents
WO1996040265A1 (en) *	1995-06-07	1996-12-19	The Regents Of The University Of California	Stabilization of polynucleotide complexes
MY120063A (en) *	1997-12-09	2005-08-30	Lilly Co Eli	Stabilized teriparatide solutions
CA2321467A1 (en) *	1998-02-18	1999-08-26	Theryte Limited	Treating cancer
PT1373215E (pt) *	2001-03-30	2006-12-29	Uni S Of A R By The S D Of H H	Derivado de geldanamicina e metodo de tratamento de cancro utilizando o mesmo
US6872715B2 (en) *	2001-08-06	2005-03-29	Kosan Biosciences, Inc.	Benzoquinone ansamycins
US7465718B2 (en) *	2002-02-08	2008-12-16	Conforma Therapeutics Corporation	Ansamycins having improved pharmacological and biological properties
CN101912601B (zh) *	2002-06-21	2012-08-29	诺和诺德医疗保健公司	因子vii多肽的稳定化固体组合物
US7282493B2 (en) *	2003-12-23	2007-10-16	Infinity Pharmaceuticals, Inc.	Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20060019941A1 (en) *	2003-12-23	2006-01-26	Infinity Pharmaceuticals, Inc.	Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20070048323A1 (en) *	2004-02-20	2007-03-01	Rubin J P	Antibody treatment of lipomatous tumors
WO2006098761A2 (en) *	2005-03-11	2006-09-21	The Regents Of The University Of Colorado	Hsp90 inhibitors, methods of making and uses therefor
EP1906950A4 (en) *	2005-06-21	2008-09-24	Infinity Discovery Inc	ANSAMYCIN FORMULATIONS AND METHODS OF USE
CN101360492A (zh) *	2005-12-01	2009-02-04	康福玛医药公司	含安莎霉素的组合物
EP2529621B1 (en) *	2006-09-22	2016-10-05	Pharmacyclics LLC	Inhibitors of bruton's tyrosine kinase

2008
- 2008-04-11 BR BRPI0810835-8A patent/BRPI0810835A2/pt not_active IP Right Cessation
- 2008-04-11 EP EP08745625A patent/EP2134338A1/en not_active Withdrawn
- 2008-04-11 CA CA002684211A patent/CA2684211A1/en not_active Abandoned
- 2008-04-11 US US12/101,473 patent/US20080255080A1/en not_active Abandoned
- 2008-04-11 CN CN200880019951A patent/CN101677991A/zh active Pending
- 2008-04-11 JP JP2010503239A patent/JP2010523710A/ja not_active Withdrawn
- 2008-04-11 AU AU2008240179A patent/AU2008240179A1/en not_active Abandoned
- 2008-04-11 MX MX2009010808A patent/MX2009010808A/es unknown
- 2008-04-11 WO PCT/US2008/060063 patent/WO2008128063A1/en not_active Ceased
2009
- 2009-10-01 IL IL201283A patent/IL201283A0/en unknown

Also Published As

Publication number	Publication date
EP2134338A1 (en)	2009-12-23
US20080255080A1 (en)	2008-10-16
WO2008128063A1 (en)	2008-10-23
AU2008240179A1 (en)	2008-10-23
IL201283A0 (en)	2010-05-31
CN101677991A (zh)	2010-03-24
JP2010523710A (ja)	2010-07-15
CA2684211A1 (en)	2008-10-23
MX2009010808A (es)	2009-10-29

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0814188A2 (pt)	2014-10-14	Formulações
BRPI0814252A2 (pt)	2015-04-14	Formulações de anticorpo
PT2889310T (pt)	2018-03-26	Formulações de anticorpo
DK2068886T3 (da)	2013-11-18	Lipidholdige præparater
ES2527409T4 (es)	2015-03-11	Formulaciones de inhibidores de DPP IV
EP2131650A4 (en)	2015-02-18	PERFUSION REGULATION
EP2157090A4 (en)	2011-09-07	PYRAZINAMIDE COMPOUND
DE602008006301D1 (de)	2011-06-01	Koaxialnadelanordnung
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
EP2188984A4 (en)	2010-11-24	TS-PACKAGE-GROOMING
EP2160187A4 (en)	2011-08-03	SPIROINDALONE
DE602007007755D1 (de)	2010-08-26	Fußplatte
DK2125048T3 (da)	2014-10-13	Præparat
BRPI0812994A2 (pt)	2014-12-23	Microbiocidas
DE602008004695D1 (de)	2011-03-10	Katalysatorträgerwabe
EP2151172A4 (en)	2012-10-17	LIGHT EMITTING DEVICE
EP2182216A4 (en)	2015-10-28	COMPRESSOR WITH ONE SCREW
DE602008000912D1 (de)	2010-05-20	Schaltanlage
BRPI0809653A2 (pt)	2014-10-07	Formulações líquidas de manoproteína
FI20075310A0 (fi)	2007-05-03	Aksiaalivuoinduktiosähkökone
EP2174732A4 (en)	2011-05-04	can seamer
EP2209817A4 (en)	2011-09-21	ANTIVIRAL COMPOSITIONS
FI20075115A0 (fi)	2007-02-16	Tuloilmayksikkö
DE602007008359D1 (de)	2010-09-23	Hemdendbearbeitungsmaschine
IS8612A (is)	2008-08-20	Stöðugar statínlyfjasamsetningar